Who Paid My Doc Search
Menu
Product Program year 2025 Source: CMS Open Payments

VOXZOGO 1.2mg

Drug Achondroplasia

NDC 68135-181-93

Open in the dashboard

General payments

$973,149

3,022 payments

Research payments

$10,536,523

1,234 payments

Through program year 2025, $973,149 in general payments and $10,536,523 in research payments were reported against VOXZOGO 1.2mg (Achondroplasia).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $432,778 1,481
2025 Research $6,851,534 776
2024 General $499,564 1,443
2024 Research $3,684,989 458
2023 General $40,493 83
2022 General $314 15

Breakdown

Who paid General payments · program years 2022–2025
  1. BioMarin Pharmaceutical Inc. $973,149 3,022 payments
Top recipients General payments · program year 2025
  1. Philippe Backeljauw Pediatric Endocrinology · Cincinnati, OH $88,430 20% · 76 payments
  2. Cathleen Raggio Pediatric Orthopaedic Surgery · Uniondale, NY $50,406 12% · 31 payments
  3. Julie Hoover-Fong Clinical Genetics (M.D.) · Baltimore, MD $41,802 10% · 20 payments
  4. Amrit Bhangoo Pediatric Endocrinology · Long Beach, CA $22,922 5% · 22 payments
  5. Janet Legare Developmental - Behavioral Pediatrics · Madison, WI $21,902 5% · 27 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pediatric Endocrinology Pediatrics $183,560 43% · 64 practitioners
  2. Clinical Genetics (M.D.) Medical Genetics $83,862 20% · 23 practitioners
  3. Pediatric Orthopaedic Surgery Orthopaedic Surgery $58,160 14% · 7 practitioners
  4. Developmental - Behavioral Pediatrics Pediatrics $21,949 5% · 2 practitioners
  5. Neurological Surgery $20,518 5% · 3 practitioners

The top 5 of 48 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Ohio $103,533 24% · 87 recipients
  2. New York $69,909 16% · 55 recipients
  3. California $52,120 12% · 85 recipients
  4. Maryland $42,158 10% · 6 recipients
  5. Texas $28,902 7% · 187 recipients

The top 5 of 45 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Records

3,022 general · 1,234 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record